Marty Makary is one step closer to becoming the head of the Food and Drug Administration. On March 13, the Senate Health, ...

The Senate Health, Education, Labor, and Pensions Committee approved Dr. Jayanta Bhattacharya’s nomination to be NIH director ...

ASC47, an adipose-targeted muscle-preserving weight loss drug candidate for the treatment of obesity, demonstrated a half-life of up to 26 days and 40 days, respectively, in Phase Ib single ...

Demand for Wegovy and Zepbound is booming, but supply issues and limited insurance coverage have curtailed access to the pricey medications.

“Obesity is one of many cardio-renal-metabolic diseases, which together represent one of the fastest growing health challenges worldwide,” said Boehringer’s head of human pharma, Carinne ...

The FDA has relied on food companies for decades to determine whether their ingredients are safe. Some chemicals and ...

The U.S. Food and Drug Administration's chief counsel, Hilary Perkins, has resigned, the federal agency said in a post on ...

Janssen's head of oncology R&D. "We look forward to working with the FDA in their review of our teclistamab submission." Teclistamab is a companion bispecific to Janssen's talquetamab, a ...

Mar. 3, 2025 — Obesity rates are set to skyrocket, with one in six children and adolescents worldwide forecast to be obese by 2050, according to a new study. But with significant increases ...

More than half of all adults and a third of children, teenagers and young adults around the world are predicted to be overweight or obese by 2050. The findings come from a new study of global data ...